Yu-chun C. Lone
Villejuif, 94802, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impact of Nanotechnology on Glioblastoma Studies: From Brain Stem Cells to Neoplastic Development and Cancer Gene Therapy.
Journal: Frontiers in bioscience (Elite edition)
Published: February 27, 2025
Mechanism of Glioblastoma Treatment Targeting Growth Factors: IGF-I Case Using Gene, Immune, Phytochemicals, and Nanotechnologies.
Journal: CNS & neurological disorders drug targets
Published: December 05, 2024
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma.
Journal: Current medicinal chemistry
Published: December 05, 2022
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients.
Journal: Cancer immunology, immunotherapy : CII
Published: January 03, 2019
Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells.
Journal: PloS one
Published: January 27, 2016
The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope.
Journal: Haematologica
Published: September 21, 2015
Characterization of effector components from the humoral and cellular immune response stimulated by melanoma cells exhibiting modified IGF-1 expression.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 11, 2014
Predictive immunogenicity of Refacto AF.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 21, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026